Using atropine eyedrops to treat myopia in children
Atropine 0.01% Eyedrops for Evolutive Myopia Treatment in Children. MYOPSTOP
This study tests whether daily atropine eyedrops can help children with worsening nearsightedness see better.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne Academic / other |
| Locations | 1 site (Saint-Etienne) |
| Trial ID | NCT04252989 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on the treatment of evolutive myopia in children using atropine 0.01% eyedrops, administered once daily. The study aims to collect data on the effectiveness of this treatment, which has shown promising results in clinical practice since 2017 at the hospital of Saint-Etienne. By building a comprehensive database, the investigators hope to publish their findings and share their experiences regarding the treatment of myopia in the French pediatric population.
Who should consider this trial
Good fit: Ideal candidates for this study are children with active myopia who are being treated with atropine 0.01% eyedrops.
Not a fit: Patients who may not benefit from this study include those who are non-compliant with the treatment regimen.
Why it matters
Potential benefit: If successful, this treatment could significantly slow the progression of myopia in children, potentially reducing the risk of severe vision complications later in life.
How similar studies have performed: Other studies have shown promising results with atropine treatment for myopia, indicating that this approach is supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children with active myopia treated with ATROPINE 0.01% eye drops * patient affiliated with a social security organization * agreement of both parents Exclusion Criteria: * non compliance with treatment
Where this trial is running
Saint-Etienne
- CHU de Saint Etienne — Saint-Etienne, France (Recruiting)
Study contacts
- Principal investigator: Marie Caroline TRONE — CHU de Saint Etienne
- Study coordinator: Marie Caroline TRONE
- Email: m.caroline.trone@chu-st-etienne.fr
- Phone: 04 77 82 94 28
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.